Avidity Partners Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-210,000
| Closed | -$3.32M | – | 75 |
|
|
2024
Q4 | $3.32M | Sell |
210,000
-83,200
| -28% | -$1.32M | 0.33% | 54 |
|
|
2024
Q3 | $17M | Sell |
293,200
-50,000
| -15% | -$2.9M | 0.87% | 47 |
|
|
2024
Q2 | $15.7M | Buy |
343,200
+133,500
| +64% | +$6.1M | 0.67% | 53 |
|
|
2024
Q1 | $13.9M | Buy |
+209,700
| New | +$13.9M | 0.45% | 60 |
|
|
2021
Q4 | – | Sell |
-145,100
| Closed | -$5.74M | – | 104 |
|
|
2021
Q3 | $5.74M | Buy |
+145,100
| New | +$5.74M | 0.13% | 79 |
|
|
2021
Q1 | – | Sell |
-40,000
| Closed | -$2.82M | – | 108 |
|
|
2020
Q4 | $2.82M | Buy |
+40,000
| New | +$2.82M | 0.09% | 86 |
|